Genome Alberta Profiles RID: From Discovery to Market

Genome Alberta’s From Discovery to Market series profiles Rapid Infection Diagnostics Inc. (RID): how more than a decade of University of Calgary research became a company, the role of Genome Alberta and Genome Canada funding, and RID’s path to regulatory approval in Canada and the U.S. Read the full feature on Genome Alberta.